In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Deepika PanthamDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0009-0007-8736-0234 Monica ArgenzianoDepartment of Scienza e Tecnologia del Farmaco, University of Torino, 10125 Torino, Italy.ORCID 0000-0002-8485-7460 Foteini ChristakiDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Piemonte Orientale, 28100 Novara, Italy.
Nausicaa ClementeDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Piemonte Orientale, 28100 Novara, Italy.
Chiara ColomboDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Piemonte Orientale, 28100 Novara, Italy.
Elisa BenettiDepartment of Scienza e Tecnologia del Farmaco, University of Torino, 10125 Torino, Italy.ORCID 0000-0002-4481-0756 Stefania PizzimentiDepartment of Clinical and Biological Sciences, University of Torino, 10125 Torino, Italy.ORCID 0000-0001-6937-8632 Umberto DianzaniDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Piemonte Orientale, 28100 Novara, Italy.
Ian StoppaDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0009-0004-8721-5537 Roberta CavalliDepartment of Scienza e Tecnologia del Farmaco, University of Torino, 10125 Torino, Italy.
Chiara DianzaniDepartment of Scienza e Tecnologia del Farmaco, University of Torino, 10125 Torino, Italy.ORCID 0000-0002-2246-3183 Funding
Associazione Italiana Ricerca sul Cancro IG 20714Fondazione Amici di Jean noneFondazione Cariplo 2017-0535University of Torino none
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
angiogenesisco-deliveryD4M-3A melanoma modelICOS-Fcmelanomananobubblespaclitaxeltumor growth
Identifiers
PMID41471045
PMCPMC12736336
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390